This suppression of appetite helps individuals eat less, leading to an average weight loss of up to two pounds per week with weekly injections
Competing interests MJD reported board membership and consultancy fees from Novo Nordisk, Sanofi-Aventis, Lilly, Merck, Sharp & Dohme, Boehringer Ingelheim, AstraZeneca, Servier, and Janssen
Semaglutide, a groundbreaking medication initially developed for managing Type 2 diabetes, is making waves in the medical community for its profound impact on blood pressure and lipid profiles
Intravenous glutathione is not approved by the TGA for skin whitening or lightening, and high-dose intravenous glutathione has been associated with reports of serious side effects overseas, including effects on the liver, kidneys and thyroid and, rarely, severe skin reactions